This review highlights the increasing incidence of peripartum cardiomyopathy, outlining current diagnostic, management, and pathophysiological advances.
Answers are grounded in this paper and cite their sources.
May prompt closer peripartum monitoring; leaves open optimal strategies pending prospective validation.
Peripartum cardiomyopathy is a form of heart failure that occurs in women within 1 month pre- and 5 months postdelivery. The syndrome carries a high mortality and predisposing factors are not known. The incidence and prevalence of peripartum cardiomyopathy appear to be increasing and this article aims to alert clinicians to consider a possible diagnosis of peripartum cardiomyopathy, outlines the current treatment options, and describes recent advances in the understanding of the pathophysiology of this condition.
No takes yet. Share an insight, caveat, or question.
Förster et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: